We invest in companies 
that shape the world of tomorrow.

We focus on Growth financing

Early stage

We do not invest early stage

Growth

We support your expansion
and internationalization

Follow on

We back our winners all the
way to IPO or exit

Secondary

We prefer to acquire entire portfolios

We offer strategic, operational and financial support

Public market access

We establish our assets’ brands at public investors

Flexibility

We are not tied to fund life cycles. We provide capital synchronized with our companies’ developments

Entrepreneurial experience

We founded companies ourselves and guided them (some of them) all the way to IPO

Digital business services

Our companies get preferred access to our digital business services

What we invest in

Disruption

We invest in digital, disruptive and scalable businesses driven by passionate teams
We invest in growth companies
that generate significant revenues

Growth

Profitability

We invest in companies following a visible and credible path to profitability
We invest in companies with an exit horizon of 3-5 years

Maturity

News

Exasol is named “Overall Data Analytics Company of the Year”

25.03.2021 - Analytics database provider Exasol has been named winner of the “Overall Data Analytics Company of the Year” category at the 2021 Data Breakthrough Awards. The independent market analyst Data Breakthrough recognizes outstanding companies, technologies, and products in the global data technology market with the awards. Exasol was able to win an award at […]

Read More
Qwello CEO Henrik Thiele on the current development of electromobility in Germany

23.03.2021 - The expansion of electromobility is one of the most important mobility and infrastructure developments of our time. In 2020 alone, the number of cars with electric drives in Germany doubled due to 40,000 new registrations. The increase is continuing. The rapid expansion of an efficient charging infrastructure is crucial for the attractiveness of […]

Read More
Bio-Gate CEO Marc Lloret-Grau reports on the successful cooperation with clinics in the field of innovative medical products in newspaper F.A.Z.

March 2021 - When implants and prostheses are used surgically, there is always a high risk of infection for the patient. Bio-Gate has developed the antiviral and antimicrobial implant coating “HyProtect” especially for this area. It is already being used with great success at the Regensburg University Hospital. Bio-Gate and the clinic have been cooperating […]

Read More
1 5 6 7 8 9 47
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram